Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to -$55.9 million.

  • Fortress Biotech's Net Income towards Common Stockholders rose 124.43% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.3 million, marking a year-over-year increase of 90.72%. This contributed to the annual value of -$55.9 million for FY2024, which is 18.61% up from last year.
  • Latest data reveals that Fortress Biotech reported Net Income towards Common Stockholders of -$55.9 million as of FY2024, which was up 18.61% from -$68.7 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Net Income towards Common Stockholders ranged from a high of -$55.9 million in FY2024 and a low of -$164.9 million during FY2021.
  • For the 3-year period, Fortress Biotech's Net Income towards Common Stockholders averaged around -$73.1 million, with its median value being -$68.7 million (2023).
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 60.07% in 2021, then skyrocketed by 42.61% in 2022.
  • Over the past 5 years, Fortress Biotech's Net Income towards Common Stockholders (Yearly) stood at -$103.0 million in 2020, then plummeted by 60.07% to -$164.9 million in 2021, then soared by 42.61% to -$94.6 million in 2022, then grew by 27.42% to -$68.7 million in 2023, then increased by 18.61% to -$55.9 million in 2024.